Hemoglobin Variants and Hemoglobinopathies — MCQs
A child presents with recurrent chest infections and abdominal pain. There is a history of 1 blood transfusion in the past. On examination, he had icterus and mild splenomegaly. Electrophoresis shows increased HbA2, HbF, and S spike. What is the likely diagnosis?
Which of the following statements is MOST accurate regarding cyanosis in methemoglobinemia?
In which type of hemoglobin are zeta 2 and gamma 2 chains present?
A 25-year-old lady presented with anemia, jaundice, and recurrent joint pains. All of the following are true except:
A patient with cyanosis and methemoglobinemia is treated with methylene blue. What is the mechanism of action of this drug?
Diagnosis of beta thalassemia is established by what?
A 45-year-old male presents with fatigue, pale skin, and jaundice. Labs reveal hemolysis and a positive direct Coombs test. What is the most likely diagnosis?
Which porphyrin forms the organic component of heme?
Why is blood stored in citrate-phosphate-dextrose considered more beneficial for hypoxic patients compared to blood stored in acidic-citrate-dextrose?
34 week primigravida punjabi khatri comes with history of consanguineous marriage, with history of repeated blood transfusion to her sibling since 8 months of age. The first diagnostic test is -
Hemoglobin Variants and Hemoglobinopathies Indian Medical PG Practice Questions and MCQs
Question 1: A child presents with recurrent chest infections and abdominal pain. There is a history of 1 blood transfusion in the past. On examination, he had icterus and mild splenomegaly. Electrophoresis shows increased HbA2, HbF, and S spike. What is the likely diagnosis?
- A. HbC disease
- B. Sickle cell disease
- C. Aplastic anemia
- D. Sickle Beta Thalassemia (Correct Answer)
Explanation: ***Sickle Beta Thalassemia*** - The combination of **sickle cell disease manifestations** (recurrent chest infections, abdominal pain, icterus, splenomegaly) with **electrophoresis showing increased HbA2, elevated HbF, and S spike** is diagnostic of **Sickle Beta Thalassemia**. - **Increased HbA2 (>3.5%)** is the key distinguishing feature that differentiates this from pure sickle cell disease. It indicates co-inheritance of a **beta-thalassemia gene** along with the **sickle cell gene**. - Clinical presentation is similar to sickle cell disease with **vaso-occlusive crises**, **acute chest syndrome**, hemolytic anemia, and organomegaly. - The severity depends on the type: S/β⁰-thalassemia (no HbA production) is clinically more severe and similar to SS disease, while S/β⁺-thalassemia (reduced HbA) tends to be milder. *Sickle cell disease* - Pure sickle cell disease (HbSS) presents with similar clinical features: recurrent chest infections, abdominal pain, hemolysis, and splenomegaly. - However, electrophoresis would show **normal or only slightly elevated HbA2 (2-3%)**, not the increased HbA2 mentioned in this case. - The presence of significantly increased HbA2 rules out pure sickle cell disease. *HbC disease* - Patients with HbC disease typically have **mild chronic hemolytic anemia** and **splenomegaly** but usually lack severe vaso-occlusive crises. - Electrophoresis would show primarily **HbC**, not an S spike. - The clinical picture is much milder than described in this case. *Aplastic anemia* - Characterized by **pancytopenia** due to bone marrow failure, leading to fatigue, infections, and bleeding tendency. - Does not involve hemolysis, icterus, or abnormal hemoglobin variants on electrophoresis. - The electrophoresis findings completely exclude this diagnosis.
Question 2: Which of the following statements is MOST accurate regarding cyanosis in methemoglobinemia?
- A. Always associated with tachycardia
- B. Caused by increased carboxyhemoglobin levels
- C. Does not improve with supplemental oxygen (Correct Answer)
- D. Can occur in both congenital and acquired forms of the disease.
Explanation: ***Does not improve with supplemental oxygen*** - In **methemoglobinemia**, the iron in hemoglobin is oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state, making it unable to bind oxygen. [1] - Therefore, despite supplemental oxygen, the **abnormal methemoglobin** cannot carry more oxygen, leading to persistent cyanosis. *Always associated with tachycardia* - While methemoglobinemia can cause **hypoxia** and compensatory **tachycardia**, it is not *always* present, especially in mild cases or if other coexisting conditions blunt the response. - The primary mechanism of cyanosis is the presence of **deoxygenated methemoglobin**, not solely the body's compensatory responses. [1] *Caused by increased carboxyhemoglobin levels* - **Carboxyhemoglobinemia** is caused by carbon monoxide poisoning, where carbon monoxide binds to hemoglobin with high affinity, preventing oxygen transport. - Methemoglobinemia is a distinct condition involving the **oxidation of iron** in hemoglobin to the ferric state. *Can occur in both congenital and acquired forms of the disease.* - This statement is generally true about methemoglobinemia itself (it can be congenital or acquired), but it doesn't directly explain the **characteristic cyanosis** and its resistance to oxygen. [1] - The question asks what is *most accurate regarding cyanosis* in the context of methemoglobinemia, focusing on the physiological manifestation rather than the disease etiology.
Question 3: In which type of hemoglobin are zeta 2 and gamma 2 chains present?
- A. Gower I
- B. Gower II
- C. Portland (Correct Answer)
- D. Fetal hemoglobin
Explanation: ***Portland*** - **Portland hemoglobin** is a primitive embryonic hemoglobin composed of **zeta (ζ) 2 and gamma (γ) 2 chains** (ζ2γ2). - It plays a role in early fetal oxygen transport, particularly in the yolk sac stage. *Gower I* - **Gower I hemoglobin** is another embryonic hemoglobin, but it consists of **zeta (ζ) 2 and epsilon (ε) 2 chains** (ζ2ε2). - This composition is crucial for oxygen delivery during the very initial stages of embryonic development. *Gower II* - **Gower II hemoglobin** is an embryonic hemoglobin made up of **alpha (α) 2 and epsilon (ε) 2 chains** (α2ε2). - It represents a transitional form as the embryo develops and starts producing alpha globin chains. *Fetal hemoglobin* - **Fetal hemoglobin (HbF)** consists of **alpha (α) 2 and gamma (γ) 2 chains** (α2γ2). - It is the predominant hemoglobin during the second and third trimesters of pregnancy and has a higher affinity for oxygen than adult hemoglobin.
Question 4: A 25-year-old lady presented with anemia, jaundice, and recurrent joint pains. All of the following are true except:
- A. HbA will be undetectable
- B. She may have retinopathy
- C. Hydroxyurea would help her
- D. She can present with pulmonary bleeds (Correct Answer)
Explanation: ***She can present with pulmonary bleeds*** - The symptoms of **anemia**, **jaundice**, and recurrent **joint pains** in a 25-year-old suggest **sickle cell anemia**. Pulmonary bleeds are not a typical or common presentation of sickle cell disease; rather, patients are more prone to **acute chest syndrome**, which involves pulmonary infiltrates, but not usually frank bleeding [2]. - While various complications can affect the lungs in sickle cell disease, **pulmonary hemorrhage** is rare and not a characteristic feature. *HbA will be undetectable* - In **sickle cell anemia (Hb SS)**, the body exclusively produces **hemoglobin S (HbS)**, meaning **adult hemoglobin (HbA)**, the normal form, is indeed undetectable [3], [4]. - This is because the patient is homozygous for the **sickle gene**, preventing the synthesis of normal beta-globin chains [4]. *She may have retinopathy* - **Sickle cell retinopathy** is a common complication due to **vaso-occlusion** in the retinal vessels, leading to ischemia, neovascularization, and potentially vision loss. - This can manifest as various stages of proliferative retinopathy, often requiring treatment to preserve vision. *Hydroxyurea would help her* - **Hydroxyurea** is a medication used to reduce the frequency and severity of **sickle cell crises** and mitigate complications [1]. - It works by increasing the production of **fetal hemoglobin (HbF)**, which interferes with the polymerization of HbS and improves red blood cell function [1].
Question 5: A patient with cyanosis and methemoglobinemia is treated with methylene blue. What is the mechanism of action of this drug?
- A. Acts as an oxygen transporter
- B. Reduces methemoglobin to hemoglobin (Correct Answer)
- C. Inhibits cytochrome c oxidase
- D. Oxidizes ferrous iron to ferric iron in hemoglobin
Explanation: ***Reduces methemoglobin to hemoglobin*** - Methylene blue acts as an **electron acceptor** for **NADPH-methemoglobin reductase**, facilitating the reduction of ferric iron (Fe3+) in methemoglobin back to its functional ferrous state (Fe2+) in hemoglobin. - This process restores the **oxygen-carrying capacity** of hemoglobin, alleviating the symptoms of methemoglobinemia. *Acts as an oxygen transporter* - Methylene blue does not directly transport oxygen; its role is to **restore the ability of hemoglobin** to bind oxygen. - Oxygen transport is the primary function of **hemoglobin**, which is compromised in methemoglobinemia. *Oxidizes ferrous iron to ferric iron in hemoglobin* - This is the opposite of methylene blue's therapeutic effect; **oxidation of ferrous iron (Fe2+) to ferric iron (Fe3+)** is precisely what causes methemoglobinemia. - Methylene blue's mechanism involves **reducing ferric iron** back to ferrous iron. *Inhibits cytochrome c oxidase* - Inhibition of **cytochrome c oxidase** is the mechanism of action for certain toxins like **cyanide**, leading to cellular hypoxia. - Methylene blue does not primarily act on the electron transport chain in this manner for the treatment of methemoglobinemia.
Question 6: Diagnosis of beta thalassemia is established by what?
- A. Hb electrophoresis (Correct Answer)
- B. NESTROFT screening test
- C. Hemoglobin A1c test
- D. Presence of target cells in blood smear
Explanation: Hb electrophoresis - Hemoglobin electrophoresis directly measures the relative proportions of different hemoglobin types (HbA, HbA2, HbF), which is crucial for identifying the characteristic reduction in HbA and elevation of HbA2 and HbF in beta thalassemia. [1] - This method provides a definitive diagnostic profile by separating hemoglobin based on their electrical charge and size, allowing for quantification of abnormal hemoglobin variants. [1] *NESTROFT screening test* - The NESTROFT (Naked Eye Single Tube Red cell Osmotic Fragility Test) is a screening tool used to identify individuals with thalassemia traits and is not a definitive diagnostic test. - While useful for mass screening due to its simplicity and cost-effectiveness, it requires confirmation with more specific tests like hemoglobin electrophoresis. [1] *Hemoglobin A1c test* - The Hemoglobin A1c (HbA1c) test is primarily used to monitor long-term blood glucose control in individuals with diabetes. [2] - It measures the percentage of hemoglobin glycated over a period of 2-3 months and has no direct diagnostic utility for thalassemia. [2] *Presence of target cells in blood smear* - The presence of target cells in a blood smear is a non-specific finding that can be observed in various conditions, including iron deficiency anemia, liver disease, and other hemoglobinopathies, in addition to thalassemia. - While suggestive of a thalassemic disorder, it is not a conclusive diagnostic criterion and requires further investigation with specific diagnostic tests.
Question 7: A 45-year-old male presents with fatigue, pale skin, and jaundice. Labs reveal hemolysis and a positive direct Coombs test. What is the most likely diagnosis?
- A. Hereditary spherocytosis
- B. Autoimmune hemolytic anemia (Correct Answer)
- C. Sickle cell anemia
- D. G6PD deficiency
Explanation: ***Autoimmune hemolytic anemia*** - The combination of **hemolysis** (fatigue, pale skin, jaundice) and a **positive direct Coombs test** is highly indicative of autoimmune hemolytic anemia [1]. - A positive direct Coombs test identifies **antibodies or complement components** bound to the surface of red blood cells, leading to their destruction [1]. *Hereditary spherocytosis* - This condition is characterized by **spherocytes** on a peripheral blood smear and an **increased osmotic fragility test** [3]. - While it causes hemolysis, a **direct Coombs test** would typically be negative as it's an intrinsic red blood cell defect, not antibody-mediated [1]. *Sickle cell anemia* - Characterized by **sickle-shaped red blood cells** and is diagnosed with **hemoglobin electrophoresis**. - While it causes hemolytic anemia, the direct Coombs test is typically **negative**, and symptoms often include **vaso-occlusive crises**. *G6PD deficiency* - This is an **X-linked recessive enzymopathy** leading to bite cells and **Heinz bodies** during oxidative stress [2]. - The direct Coombs test would be **negative**, as the hemolysis is due to enzyme deficiency, not antibodies [2].
Question 8: Which porphyrin forms the organic component of heme?
- A. Uroporphyrin
- B. Coproporphyrin
- C. Deuteroporphyrin
- D. Protoporphyrin IX (Correct Answer)
Explanation: ***Protoporphyrin IX*** - **Heme** is formed by the insertion of an **iron atom (Fe2+)** into the center of **protoporphyrin IX**. - **Protoporphyrin IX** is the immediate precursor to heme in the **heme synthesis pathway**. *Uroporphyrin* - **Uroporphyrin** is an earlier precursor in the **heme synthesis pathway** and is much more hydrophilic than protoporphyrin. - It accumulates in diseases like **congenital erythropoietic porphyria (CEP)**, leading to photosensitivity. *Coproporphyrin* - **Coproporphyrin** is an intermediate in the **heme synthesis pathway**, formed after uroporphyrinogen. - It is also more water-soluble than protoporphyrin and its accumulation can be seen in various porphyrias. *Deuteroporphyrin* - **Deuteroporphyrin** is a synthetic porphyrin or a less common natural porphyrin that is not directly involved as the organic component of heme in mammals. - While it is structurally similar to protoporphyrin, it does not serve as the direct precursor for heme formation in the human body.
Question 9: Why is blood stored in citrate-phosphate-dextrose considered more beneficial for hypoxic patients compared to blood stored in acidic-citrate-dextrose?
- A. The fall in 2,3-DPG is less. (Correct Answer)
- B. It has a higher pH level than acidic-citrate-dextrose.
- C. It is more effective in oxygen delivery.
- D. It has a longer shelf life than acidic-citrate-dextrose.
Explanation: ***The fall in 2,3-DPG is less.*** * **Citrate-phosphate-dextrose (CPD)** better preserves levels of **2,3-bisphosphoglycerate (2,3-DPG)** in stored red blood cells. * Higher 2,3-DPG levels are crucial for **oxygen unloading** from hemoglobin in tissues, which is particularly beneficial for hypoxic patients who need efficient oxygen delivery. *It has a higher pH level than acidic-citrate-dextrose.* * While CPD does maintain a **less acidic pH** than acid-citrate-dextrose (ACD), which is generally favorable for red blood cell viability, the most direct benefit for hypoxic patients relates to 2,3-DPG. * The slightly higher pH indirectly contributes to better 2,3-DPG preservation but isn't the primary reason for improved oxygen delivery. *It is more effective in oxygen delivery.* * While the *consequence* of using CPD is **more effective oxygen delivery** due to better 2,3-DPG preservation, this option describes the outcome rather than the underlying mechanism compared to the more specific answer regarding 2,3-DPG. * The increased efficacy in oxygen delivery is directly attributable to the preserved 2,3-DPG levels. *It has a longer shelf life than acidic-citrate-dextrose.* * The storage solutions primarily impact red blood cell viability and function, but the **shelf life** (typically 21-35 days depending on the anticoagulant/preservative) is generally determined by other factors, including the additive solutions used with the anticoagulant. * While CPD improves red blood cell quality, the primary advantage for hypoxic patients specifically lies in oxygen affinity rather than overall storage duration.
Question 10: 34 week primigravida punjabi khatri comes with history of consanguineous marriage, with history of repeated blood transfusion to her sibling since 8 months of age. The first diagnostic test is -
- A. HPLC
- B. Bone marrow
- C. Blood smear
- D. Hb electrophoresis (Correct Answer)
Explanation: ***Hb electrophoresis*** - The patient's history of **consanguineous marriage**, a sibling requiring **repeated blood transfusions** since 8 months of age, and Punjabi Khatri ethnicity strongly suggest a **hemoglobinopathy**, likely **beta-thalassemia major or intermedia**. - **Hemoglobin electrophoresis** is the traditional gold standard for definitive diagnosis of various hemoglobin variants and thalassemia types, identifying and characterizing abnormal hemoglobin patterns (e.g., elevated HbF, HbA2). - It remains a primary diagnostic test for hemoglobinopathies, particularly useful for pattern recognition of various thalassemia syndromes. *HPLC* - **High-performance liquid chromatography (HPLC)** is an equally valid and increasingly preferred method for diagnosing hemoglobinopathies, offering automated, precise quantification of hemoglobin fractions (HbA, HbA2, HbF). - In modern practice, HPLC is often used as a first-line screening tool due to its accuracy, reproducibility, and ability to provide quantitative data crucial for thalassemia diagnosis. - Both HPLC and Hb electrophoresis are acceptable diagnostic approaches; the choice between them depends on laboratory availability and practice patterns. For this 2013 exam, Hb electrophoresis was considered the traditional first diagnostic test. *Blood smear* - A **peripheral blood smear** would show morphological changes like **microcytic hypochromic red blood cells**, **target cells**, **anisopoikilocytosis**, and **nucleated RBCs**, which are suggestive of thalassemia. - These findings are indicative but non-specific and require confirmatory tests like hemoglobin electrophoresis or HPLC to identify the specific hemoglobin disorder and establish a definitive diagnosis. *Bone marrow* - A **bone marrow** examination would show **erythroid hyperplasia** due to increased ineffective erythropoiesis in thalassemia but is an invasive procedure and not the initial diagnostic test for hemoglobinopathies. - It provides details about cellularity and maturation but does not directly identify hemoglobin abnormalities, making it unsuitable as the first diagnostic step in suspected hemoglobinopathies.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free